Article
Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jan 2016
Hu Chunling, Hart Steven N, Bamlet William R, Moore Raymond M, Nandakumar Kannabiran, Eckloff Bruce W, Lee Yean K, Petersen Gloria M, McWilliams Robert R, Couch Fergus J
Abstract excerpt
The prevalence of germline pathogenic mutations in a comprehensive panel of cancer predisposition genes is not well-defined for patients with pancreatic ductal adenocarcinoma (PDAC). To estimate the frequency of mutations in a panel of 22 cancer predisposition genes, 96 patients unselected for a family history of cancer who were recruited to the Mayo Clinic Pancreatic Cancer patient registry over a 12-month...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
